Isolated nail psoriasis may be a sign of psoriatic arthritis

Published Date: 02 Mar 2023

In a review of 87 patients, the authors recorded the clinical and histological characteristics of patients with nail psoriasis.

Read Full News

Latest News

AI-Tomography Detects Subclinical Basal Cell Skin Cancers

AI-assisted coherence tomography shows feasibility as a method of detecting basal cell carcinomas when they are still undetectable, but clinical relevance is still being evaluated.

GLP1R Expression Tied to Male Pattern Hair Loss

A genetic analysis suggests that increased GLP1R expression is linked to higher risk for male pattern hair loss.

Social Media Tied to Heavier Chemical Product Use in Teens

Teens who follow beauty influencers and watch skincare tutorials use far more personal care products, raising concerns over chemical exposure.

Young Adult Cancer Survival Rates Accelerate

Researchers have analyzed annual survival data between AYA patients aged 15-39 years and patients in younger and older age groups between 1975 and 2017.

Better Survival Seen With Spartalizumab Addition in Melanoma

More than 500 adults with BRAF V600-mutant cutaneous melanoma were randomly assigned to receive either intravenous spartalizumab plus oral dabrafenib and trametinib or oral dabrafenib and trametinib.

Advances in MCC: Q&A With Paul Nghiem, MD, PhD

Paul Nghiem, MD, PhD, a global expert in Merkel cell carcinoma, spoke with Medscape Dermatology about recent findings and trends in MCC care and research, as well as a look into the future.

Todays Updates

How an Old Antibiotic Can Kill a Drug-Resistant Superbug

Researchers using "click chemistry" disabled a superbug's defenses against a classic antibiotic, potentially finding a way to solve antibiotic-resistant bacteria.

Todays Updates

How an Old Antibiotic Can Kill a Drug-Resistant Superbug

Researchers using "click chemistry" disabled a superbug's defenses against a classic antibiotic, potentially finding a way to solve antibiotic-resistant bacteria.

Latest News

AI-assisted coherence tomography shows feasibility as a method of detecting basal cell carcinomas when they are still undetectable, but clinical relevance is still being evaluated.

A genetic analysis suggests that increased GLP1R expression is linked to higher risk for male pattern hair loss.

Teens who follow beauty influencers and watch skincare tutorials use far more personal care products, raising concerns over chemical exposure.

Researchers have analyzed annual survival data between AYA patients aged 15-39 years and patients in younger and older age groups between 1975 and 2017.

More than 500 adults with BRAF V600-mutant cutaneous melanoma were randomly assigned to receive either intravenous spartalizumab plus oral dabrafenib and trametinib or oral dabrafenib and trametinib.

Paul Nghiem, MD, PhD, a global expert in Merkel cell carcinoma, spoke with Medscape Dermatology about recent findings and trends in MCC care and research, as well as a look into the future.

News All Time

FDA Approves First Oral Drug for Dermatomyositis in Adults

The FDA has approved brepocitinib (Lisraya), an oral JAK inhibitor, for the treatment of dermatomyositis, a rare autoimmune disease, in adults.

Early Step-Down Safe, Cost-Effective in Stable Candidiasis

Switching from an echinocandin to an azole within 5 days is not associated with worse outcomes in clinically stable adults with invasive candidiasis, a study shows.

How Safe Is Lifileucel After Patients Go Home?

The T-cell therapy’s inpatient toxicity is well-characterized, but the risks patients may face after hospital discharge have been unclear.

China Approves J&J Psoriasis Pill Icotyde, Says Drugmaker

China's drug regulator has approved Johnson & Johnson's oral pill ⁠for psoriasis, the company said on Thursday, intensifying competition in the ⁠world's second-largest...

Vulvar Lichen Sclerosus Affects 1 in 700 US Women

Vulvar lichen sclerosus shows markedly higher rates in women over 60, with White women experiencing the highest burden, a study shows.

Brepocitinib Controls Skin Disease in Dermatomyositis

Brepocitinib produces rapid and sustained improvements in skin disease, itch, and skin-related quality of life in adults with dermatomyositis.

Biologic Choice May Affect PsA Progression in Psoriasis

In patients with psoriasis, interleukin-targeting inhibitors are associated with a lower risk for psoriatic arthritis than TNF inhibitors, a long-term real-world study finds.

ctDNA Detects Postsurgical Merkel Cell Recurrence

Circulating tumor DNA surveillance detects Merkel cell carcinoma recurrence after curative-intent surgery.

Longer Targeted Therapy May Not Raise Cancer Risk in SpA

Using targeted therapy for spondyloarthritis for more than 6 months per year is not associated with an increased risk for cancer compared with using targeted therapy for shorter durations.

Data Gaps Hinder Response to Climate-Driven Infections

Climate change is reshaping infectious disease risk in Italy and beyond, highlighting the need for better diagnostics, integrated data, and stronger global cooperation.

Ruxolitinib Improves Vitiligo Outcomes in Real-World Study

Topical ruxolitinib shows sustained repigmentation through 52 weeks with improvements in anxiety and depression in patients with non-segmental vitiligo.

Clinical Crosstalk: Integrating ICIs and Strengthening Collaborative Care in NMSC

Clinical Crosstalk: Integrating ICIs and Strengthening Collaborative Care in NMSC

In 20 Different Cancers, Men More Likely to Be Diagnosed at a Later Stage

More late-stage diagnoses add to higher cancer mortality burden for men

Guidelines Help Spot Dermatomyositis Patients at High Risk for Cancer

IMACS guidelines are clinically useful for identifying high-risk populations, researchers say

Viral NeeDoh Trend Leading to Scalding Injuries, Doctors Warn

Kids are microwaving the squishy toy, making the gel inside hot enough to boil and explode

What Is the 'Barbie Peptide' and Why Is It Risky?

Dermatologists weigh in on the injectable trend

Recommended News For You

X-ray and radar technology combined to reduce cancer screening risks

EVP Beats Cisplatin for Resectable MIBC

Cancer patients want financial screening early in care, study finds

Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement

According to new studies, some cancer patients can safely forego radiation therapy.

Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers

Some low-grade prostate cancers carry higher risks than biopsy suggests

Recommended Articles For You

Clinical Frameworks in Oncology and Quality Improvement 

Octreotide's Efficacy in Reducing Transfusion Requirements in Angiodysplasia Bleeding 

Exploring the Unseen: Carcinoid Syndrome and its Impact on Quality of Life 

Unmasking the Subtle Symptoms of Colon Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Telemedicine services linked to reducing excess mortality

2.

New study links air pollution with higher rates of head and neck cancer

3.

US Mental Health Treatment Rates Rise But Gaps Persist

4.

No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances

5.

Do Anatomy Atlases Reflect Social Inequalities?

1.

Radiomics-Based Prediction of Treatment Response in Cancer

2.

Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers

3.

Ultrasound: A Promising Tool in the Fight Against Malignant Breast Cancer

4.

Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself

5.

Pharmacological Frontier of Precision Oncology, Immunotherapies, and the Evolving Art of Treatment

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

2.

Recognizing General Warning Signs of Cancer

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

4.

Recognizing Symptoms of Vitamin B12 Deficiency

5.

Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot